AOD-9604 5mg

AOD-9604 5mg — Overview

AOD-9604 is a synthetic peptide fragment derived from the C-terminus of human growth hormone (hGH), specifically spanning amino acids 176–191. Researchers first studied it to see if they could isolate hGH’s fat-metabolising properties while sidestepping the insulin-related effects that come with the full-length hormone. In preclinical models, it’s drawn steady interest for its influence on lipid metabolism and adipose tissue regulation—two areas that stay at the forefront of metabolic research.

Mechanism of Action

The peptide works by triggering lipolysis—the breakdown of stored fat—and blocking lipogenesis, the process where the body turns non-fat dietary components into body fat. It’s different from recombinant hGH because AOD-9604 doesn’t seem to boost IGF-1 production or impact blood glucose levels in the same way. This makes it a practical tool for research settings where the goal is to study fat metabolism in relative isolation.

On a molecular level, AOD-9604 is thought to interact with beta-3 adrenergic receptors, mimicking some of the fat-burning signals triggered by the full growth hormone molecule. It also appears to stimulate the resting metabolic rate in adipose tissue, though researchers are still characterising the precise downstream signalling cascade in the literature.

Research Applications

Most published work on AOD-9604 centres on its metabolic effects, but researchers have also explored its relevance in musculoskeletal contexts. Early rodent studies suggested it might assist with cartilage and bone repair—specifically through interaction with TGF-β signalling pathways. It is a discovery that opened up a secondary avenue of investigation beyond simple lipid metabolism.

If your lab is looking into obesity models or adipogenesis pathways, AOD-9604 5mg provides a solid, well-characterised starting point for your research. It’s frequently studied alongside other compounds to get a broader view of metabolic disruption. For instance, many researchers pair it with Tesamorelin 10mg, a GHRH analogue that works through different visceral fat-reduction mechanisms. Others might combine it with 5-amino-1MQ 10mg to target the NNMT enzyme pathway, as these two have shown interesting complementary effects in metabolic tissue studies. This product is for research purposes only and is not intended for human administration; it should only be handled by qualified investigators.

Some researchers also pair AOD-9604 5mg with Fragment 176-191 2mg. Since they’re structurally identical but come in a lower unit dose, it’s easier to establish dose-response curves across a wider range without burning through full vials at every data point.

Purity, Stability & Storage

This vial contains AOD-9604 5mg supplied as a lyophilised (freeze-dried) powder. We’ve used lyophilisation because it’s the standard for peptide research; it significantly extends shelf life at room temperature compared to liquid formats. Once you’ve reconstituted it with a proper solvent (typically bacteriostatic water), the solution needs to stay refrigerated and be used within a reasonable experimental window.

Purity matters more than most things in a research setting, as even minor impurities can introduce variables that mess with your results or create unwanted artefacts. We make sure every batch is independently tested to verify its identity and purity before it’s ever sent out. When you’re setting up your experimental records, don’t forget to request the relevant certificate of analysis (COA) for your specific lot.

Comparison with Related Peptides

It’s important to distinguish AOD-9604 from other growth hormone–adjacent peptides you’ll find in the research landscape. Secretagogues like GHRP-2 5mg or Hexarelin 2mg work upstream by stimulating the pituitary to release GH, but AOD-9604 is a downstream fragment that bypasses pituitary involvement entirely. This distinction matters for methodology. Researchers studying peripheral adipose signalling rather than the HPG/GH axis often prefer fragments like AOD-9604 because it sidesteps that neuroendocrine complexity. This product is for research purposes only and is not intended for human administration; it should only be used by qualified investigators.

In the same vein, while full-length IGF-1 analogues like IGF-1 LR3 1mg show broad anabolic and metabolic activity, AOD-9604’s narrower profile is different. It makes it much easier for researchers to attribute any observed effects specifically to lipid pathway modulation.

Intended Use

AOD-9604 5mg is supplied strictly for research purposes only. It’s intended for use in laboratory and preclinical research settings by qualified investigators, and it’s not intended for human administration.

References

• Heffernan M, et al. “The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.” Endocrinology. 2001;142(12):5182–5189.
• Stier H, et al. “Safety and tolerability of the growth hormone fragment AOD9604 in healthy adults.” Clin Exp Pharmacol Physiol. 2013;40(5):303–310.
• Ng FM, et al. “Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.” Horm Res. 2000;53(6):274–278.
• Risøe PK, et al. “The synthetic fragment of human growth hormone, AOD9604, exerts a regenerative effect on cartilage.” J Orthop Res. 2015;33(4):532–537.